Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 11
Submit an article Journal homepage
499
Views
61
CrossRef citations to date
0
Altmetric
Theme: Alzheimer's Disease - Review

The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Adriana P Hermida Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA. [email protected]; Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA. [email protected]
,
William M McDonald Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA. [email protected]; Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA. [email protected]
,
Kyle Steenland Rollins School of Public Health, 1518 Clifton Road, NE, Claudia Nance Rollins Building, 2005 Atlanta, GA 30322, USA; Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA. [email protected]
&
Allan Levey Chair Department of Neurology, Director of Emory Alzheimer’s Research Center, Emory University, 101 Woodruff Circle, WMB, suite 6000, Atlanta, GA, USA; Chair Department of Neurology, Director of Emory Alzheimer’s Research Center, Emory University, 101 Woodruff Circle, WMB, suite 6000, Atlanta, GA, USA
Pages 1339-1350 | Published online: 09 Jan 2014

References

  • Turró-Garriga O, López-Pousa S, Vilalta-Franch J et al. Annual economic cost of informal care in Alzheimer’s disease. Rev. Neurol. 51(4), 201–207 (2010).
  • No authors listed. 2012 Alzheimer’s disease facts and figures. Alzheimers Dement. 8(2), 131–168 (2012).
  • Steffens DC, Fisher GG, Langa KM, Potter GG, Plassman BL. Prevalence of depression among older Americans: the Aging, Demographics and Memory Study. Int. Psychogeriatr. 21(5), 879–888 (2009).
  • Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol. Med. 40(2), 225–237 (2010).
  • Petersen RC, Roberts RO, Knopman DS et al. Mild cognitive impairment: ten years later. Arch. Neurol. 66(12), 1447–1455 (2009).
  • Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch. Neurol. 66(9), 1151–1157 (2009).
  • Hickie I, Naismith S, Ward PB et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br. J. Psychiatry 186, 197–202 (2005).
  • MacQueen GM, Campbell S, McEwen BS et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl Acad. Sci. USA 100(3), 1387–1392 (2003).
  • Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 161(4), 598–607 (2004).
  • Camus V, Kraehenbühl H, Preisig M, Büla CJ, Waeber G. Geriatric depression and vascular diseases: what are the links? J. Affect. Disord. 81(1), 1–16 (2004).
  • Hickie I, Naismith S, Ward PB et al. Vascular risk and low serum B12 predict white matter lesions in patients with major depression. J. Affect. Disord. 85(3), 327–332 (2005).
  • Rodríguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and Alzheimer’s disease. Prog. Neurobiol. (2012).
  • Wixey JA, Reinebrant HE, Buller KM. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia–ischemia in the immature rat brain. J. Neuropathol. Exp. Neurol. 70(1), 23–35 (2011).
  • Hurley LL, Tizabi Y. Neuroinflammation, neurodegeneration, and depression. Neurotox. Res. doi:10.1007/s12640-012-9348-1 (2012) (Epub ahead of print).
  • Mondelli V, Cattaneo A, Belvederi Murri M et al. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J. Clin. Psychiatry 72(12), 1677–1684 (2011).
  • Schuitemaker A, Dik MG, Veerhuis R et al. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol. Aging 30(11), 1885–1889 (2009).
  • Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 21(1), 9–19 (2007).
  • Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27(1), 24–31 (2006).
  • Duong T, Nikolaeva M, Acton PJ. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease. Brain Res. 749(1), 152–156 (1997).
  • Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem. Res. 32(10), 1749–1756 (2007).
  • Green RC, Cupples LA, Kurz A et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 60(5), 753–759 (2003).
  • Dotson VM, Beydoun MA, Zonderman AB. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75(1), 27–34 (2010).
  • Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75(1), 35–41 (2010).
  • Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatr. 75(12), 1662–1666 (2004).
  • Becker JT, Chang YF, Lopez OL et al. Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am. J. Geriatr. Psychiatry 17(8), 653–663 (2009).
  • Geda YE. Blowing hot and cold over depression and cognitive impairment. Neurology 75(1), 12–14 (2010).
  • Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch. Gen. Psychiatry 69(5), 493–498 (2012).
  • MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol. Psychiatry 16(3), 252–264 (2011).
  • Butters MA, Young JB, Lopez O et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin. Neurosci. 10(3), 345–357 (2008).
  • McEwen BS. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105–122 (1999).
  • MacQueen GM. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J. Psychiatry Neurosci. 34(5), 343–349 (2009).
  • Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 6(7), 611–619 (2007).
  • Vogelzangs N, Beekman AT, Boelhouwer IG et al. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J. Clin. Psychiatry 72(5), 598–604 (2011).
  • Vogelzangs N, Suthers K, Ferrucci L et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32(2), 151–159 (2007).
  • Geda YE. Mild cognitive impairment in older adults. Curr. Psychiatry Rep. 14(4), 320–327 (2012).
  • Reisberg B, Ferris SH, de Leon MJ et al. The stage specific temporal course of Alzheimer’s disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. Prog. Clin. Biol. Res. 317, 23–41 (1989).
  • Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56(3), 303–308 (1999).
  • Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7(3), 270–279 (2011).
  • Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7(3), 280–292 (2011).
  • Rozzini L, Vicini Chilovi B, Conti M et al. Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 25(1), 32–36 (2008).
  • Ellison JM, Harper DG, Berlow Y, Zeranski L. Beyond the “C” in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment. CNS Spectr. 13(1), 66–72 (2008).
  • Ihle-Hansen H, Thommessen B, Wyller TB et al. Incidence and subtypes of MCI and dementia 1 year after first-ever stroke in patients without pre-existing cognitive impairment. Dement. Geriatr. Cogn. Disord. 32(6), 401–407 (2011).
  • Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol. Psychiatry 60(12), 1304–1305 (2006).
  • Krishnan KR, Taylor WD, McQuoid DR et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol. Psychiatry 55(4), 390–397 (2004).
  • Robert PH, Berr C, Volteau M et al.; PréAL study. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer’s disease: a one-year follow-up study. Clin. Neurol. Neurosurg. 108(8), 733–736 (2006).
  • Geda YE, Knopman DS, Mrazek DA et al. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch. Neurol. 63(3), 435–440 (2006).
  • Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch. Gen. Psychiatry 63(3), 273–279 (2006).
  • Panza F, Capurso C, D’Introno A et al. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int. J. Geriatr. Psychiatry 23(7), 726–734 (2008).
  • Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology 68(24), 2085–2092 (2007).
  • Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women’s Health Initiative Memory Study. J. Am. Geriatr. Soc. 59(1), 57–66 (2011).
  • Unverzagt FW, Ogunniyi A, Taler V et al. Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis. Assoc. Disord. 25(1), 4–10 (2011).
  • Ravaglia G, Forti P, Lucicesare A et al. Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort. Am. J. Geriatr. Psychiatry 16(10), 834–843 (2008).
  • Köhler S, Thomas AJ, Barnett NA, O’Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol. Med. 40(4), 591–602 (2010).
  • Modrego PJ, Ferrández J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch. Neurol. 61(8), 1290–1293 (2004).
  • Edwards ER, Spira AP, Barnes DE, Yaffe K. Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia. Int. J. Geriatr. Psychiatry 24(7), 716–722 (2009).
  • Houde M, Bergman H, Whitehead V, Chertkow H. A predictive depression pattern in mild cognitive impairment. Int. J. Geriatr. Psychiatry 23(10), 1028–1033 (2008).
  • Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer’s Disease Cooperative Study Group. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 72(24), 2115–2121 (2009).
  • Teng E, Lu PH, Cummings JL. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 24(4), 253–259 (2007).
  • Vicini Chilovi B, Conti M, Zanetti M, Mazzù I, Rozzini L, Padovani A. Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement. Geriatr. Cogn. Disord. 27(4), 390–398 (2009).
  • Gabryelewicz T, Styczynska M, Luczywek E et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int. J. Geriatr. Psychiatry 22(6), 563–567 (2007).
  • Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68(19), 1596–1602 (2007).
  • Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer’s disease in 30 US Alzheimer’s disease centers. J. Alzheimers Dis. 31(2), 265–275 (2012).
  • Artero S, Ancelin ML, Portet F et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J. Neurol. Neurosurg. Psychiatr. 79(9), 979–984 (2008).
  • Köhler S, van Boxtel M, Jolles J, Verhey F. Depressive symptoms and risk for dementia: a 9-year follow-up of the Maastricht Aging Study. Am. J. Geriatr. Psychiatry 19(10), 902–905 (2011).
  • Christensen MV, Kyvik KO, Kessing LV. Cognitive function in unaffected twins discordant for affective disorder. Psychol. Med. 36(8), 1119–1129 (2006).
  • Dlugaj M, Gerwig M, Wege N et al. Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study. J. Alzheimers Dis. 28(3), 503–514 (2012).
  • Stephan BC, Hunter S, Harris D et al. The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol. Psychiatry 17(11), 1059–1076 (2012).
  • Stephan BC, Brayne C, Savva GM, Matthews FE; Medical Research Council Cognitive Function and Ageing Study. Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing 40(4), 501–507 (2011).
  • Akiyama H, Barger S, Barnum S et al. Inflammation and Alzheimer’s disease. Neurobiol. Aging 21(3), 383–421 (2000).
  • Buxbaum JD, Oishi M, Chen HI et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer b/A4 amyloid protein precursor. Proc. Natl Acad. Sci. USA 89(21), 10075–10078 (1992).
  • Wood JA, Wood PL, Ryan R et al. Cytokine indices in Alzheimer’s temporal cortex: no changes in mature IL-1 b or IL-1RA but increases in the associated acute phase proteins IL-6, a 2-macroglobulin and C-reactive protein. Brain Res. 629(2), 245–252 (1993).
  • O’Brien D, Skelton KH, Owens MJ, Nemeroff CB. Are CRF receptor antagonists potential antidepressants? Hum. Psychopharmacol. 16(1), 81–87 (2001).
  • Carpenter LL, Heninger GR, Malison RT, Tyrka AR, Price LH. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. J. Affect. Disord. 79(1–3), 285–289 (2004).
  • Doecke JD, Laws SM, Faux NG et al.; The Alzheimer’s Disease Neuroimaging Initiative and Australian Imaging Biomarker and Lifestyle Research Group. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch. Neurol. 1–8 (2012).
  • Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67(5), 446–457 (2010).
  • Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor a in patients with depression: normalization during electroconvulsive therapy. J. ECT 19(4), 183–188 (2003).
  • Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71(2), 171–186 (2009).
  • Hu WT, Holtzman DM, Fagan AM et al.; For the Alzheimer’s Disease Neuroimaging Initiative. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79(9), 897–905 (2012).
  • Kravitz BA, Corrada MM, Kawas CH. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement. 5(4), 318–323 (2009).
  • Lindqvist D, Janelidze S, Hagell P et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 66(3), 287–292 (2009).
  • Olsson B, Hertze J, Lautner R et al. Microglial markers are elevated in the prodromal phase of Alzheimer’s disease and vascular dementia. J. Alzheimers Dis. doi:10.3233/JAD-2012-120787 (2012) (Epub ahead of print).
  • Soares HD, Potter WZ, Pickering E et al.; The Biomarkers Consortium Alzheimer’s Disease Plasma Proteomics Project. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol. 69(10), 1310–1317 (2012).
  • Zaciragic A, Lepara O, Valjevac A et al. Elevated serum C-reactive protein concentration in Bosnian patients with probable Alzheimer’s disease. J. Alzheimers Dis. 12(2), 151–156 (2007).
  • Zorrilla EP, Luborsky L, McKay JR et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15(3), 199–226 (2001).
  • Raison CL, Rutherford RE, Woolwine BJ et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Arch. Gen. Psychiatry 1–11 (2012).
  • Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J. Am. Geriatr. Soc. 45(5), 570–578 (1997).
  • Robert P, Onyike CU, Leentjens AF et al. Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur. Psychiatry 24(2), 98–104 (2009).
  • Robert PH. For a unified definition of apathy. J. Psychosom. Res. 71(3), 197 (2011).
  • Mortby ME, Maercker A, Forstmeier S. Apathy: a separate syndrome from depression in dementia? A critical review. Aging Clin. Exp. Res. doi:10.3275/8105 (2011) (Epub ahead of print).
  • Hakim AM. Depression, strokes and dementia: new biological insights into an unfortunate pathway. Cardiovasc. Psychiatry Neurol. 2011, 649629 (2011).
  • Ariyo AA, Haan M, Tangen CM et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102(15), 1773–1779 (2000).
  • Evans DL, Nemeroff CB. The dexamethasone suppression test in organic affective syndrome. Am. J. Psychiatry 141(11), 1465–1467 (1984).
  • Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am. Heart J. 140(Suppl. 4), 57–62 (2000).
  • Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60(4), 436–444 (1994).
  • Mattsson N, Rosén E, Hansson O et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78(7), 468–476 (2012).
  • Knight WD, Okello AA, Ryan NS et al. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 134(Pt 1), 293–300 (2011).
  • Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Fenema-Notestine C, Dale AM; Alzheimer’s Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer’s disease. Proc. Natl Acad. Sci. USA 106(49), 20954–20959 (2009).
  • Aisen PS. Inflammation and Alzheimer’s disease: mechanisms and therapeutic strategies. Gerontology 43(1–2), 143–149 (1997).
  • Wuwongse S, Chang RC, Law AC. The putative neurodegenerative links between depression and Alzheimer’s disease. Prog. Neurobiol. 91(4), 362–375 (2010).
  • Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 59(12), 1136–1143 (2006).
  • Kessing LV. Depression and the risk for dementia. Curr. Opin. Psychiatry (2012).
  • Mackenzie IR, Munoz DG. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50(4), 986–990 (1998).
  • Fiebich BL, Hofer TJ, Lieb K et al. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and α1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-α. Neuropharmacology 38(9), 1325–1333 (1999).
  • Jaturapatporn D, Isaac MG, McCleery J, Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. Cochrane Database Syst. Rev. 2, CD006378 (2012).
  • Ralay Ranaivo H, Craft JM, Hu W et al. Glia as a therapeutic target: selective suppression of human amyloid-b-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26(2), 662–670 (2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.